Monday 11 April 2016

• 17:00 - Innovation in Immunotherapy
  Professor Paresh Vyas (University of Oxford, Weatherall Institute of Molecular Medicine), Prof Vincenzo Cerundolo (MRC Human Immunology Unit, WIMM, University of Oxford), Dr Bent Jakobsen (Chief Scientific Officer, Immunocore), Martin Pule (Cancer Institute, UCL), Dr Robert Wilkinson (Director of Oncology Research, MedImmune Ltd), Prof Sarah Gilbert (Professor of Vaccinology at Oxford University, Founder of Vaccitech), Dr Eliot Forster (CEO of Immunocore Ltd), Dr Lucinda Crabtree (Senior Investment Analyst, Woodford Investment Management LLP), Prof Mark Middleton (Lead Cancer Clinician for the Oxford University Hospitals NHS Foundation Trust and deputy director of the Cancer Research UK Oxford Centre)

Friday 15 September 2017

• 14:00 - Seminar Cancelled (Amino acid degrading enzymes and their role in tumour immune escape mechanisms)
  Status: This talk has been cancelled
  Prof Vincenzo Cerundolo (MRC Human Immunology Unit, WIMM, University of Oxford)
  Jenner Seminars

Tuesday 26 May 2015

• 09:15 - Defining and predicting the cross-reactivity of the T cell receptor
  Status: This talk is in preparation - details may change
  Dr Michael Birnbaum (Stanford University School of Medicine, USA)

Wednesday 9 September 2015

• 13:30 - Opposing Roles of Obesity on Hematopoietic Stem Cell Transplantation
  Dr William J Murphy (Dept of Internal Medicine-Division of Haematology/Oncology, University of California)
  WIMM Occasional Seminars

Wednesday 23 September 2015

• 13:30 - Exploring Functional Effects of Genetically Determined Gene Expression: From Inflammation to the DNA Damage Response
  Dr Ben Fairfax (University of Oxford)
  MRC TIDU Wednesday Seminar Series

Tuesday 29 September 2015

• 11:00 - Systems Immunology – Using an Holistic Approach to Understand the Molecular Mechanisms of Immunity
  Dr Helder Nakaya (Assistant Professor - Dept. of Clinical Analyses & Toxicology, University of Sao Paulo, Brazil and Adjunct Professor, Dept. of Pathology, Emory University School of Medicine)
  WIMM Occasional Seminars

Wednesday 16 December 2015

• 13:30 - ImmTAcs - Can a Biologic Eestablish the Missing Link Between Cancer and T Cells?
  Dr Bent Jakobsen (Chief Scientific Officer, Immunocore)
  MRC TIDU Wednesday Seminar Series

Friday 18 December 2015

• 10:30 - The Use of Dendritic Cells in Cancer Immunotherapy
  Professor Derek Hart (ANZAC Research Institute, Dendritic Cell Biology and Therapeutics Group, Concord, Australia)
  WIMM Occasional Seminars

Wednesday 17 February 2016

• 13:30 - Breaking Bad and Creating Good: Exploiting DNA as an Immune Adjuvant to Treat Cancer and Autoimmune Syndromes
  Professor Andrew Mellor (Professor of Translational Immunology, Institute of Cellular Medicine, Newcastle University)
  MRC TIDU Wednesday Seminar Series

Wednesday 16 March 2016

• 13:30 - Natural Killer cell receptors and MHC class I ligands in humans and chimpanzees
  Professor Peter Parham (Professor of Structural Biology and of Microbiology and Immunology, Stanford University, USA)
  MRC TIDU Wednesday Seminar Series

Monday 21 March 2016

• 13:00 - The control of T cell metabolism and differentiation
  Prof Doreen Cantrell (Wellcome Trust Biocentre)
  WIMM MONDAY SEMINARS

Friday 15 April 2016

• 09:15 - Autophagy defects in monogenic forms of Crohn's Disease
  Status: This talk is in preparation - details may change
  Sumeet Pandey (Uhlig Group)
  MRC TIDU Friday Morning Lab Meetings

Friday 22 April 2016

• 09:15 - A role for LYVE-1 in the lymphatic dissemination of hyaluronan encapsulated Group A Streptococci
  Prof David Jackson (WIMM HIU)
  MRC TIDU Friday Morning Lab Meetings

Friday 29 April 2016

• 09:15 - Exploring mechanisms of NOD2 function in innate immunity
  Daniele Corridoni (University of Oxford)
  MRC TIDU Friday Morning Lab Meetings

Friday 6 May 2016

• 09:15 - A vaccine against Salmonella for Africa. Opportunities and Challenges
  Prof Cal Maclennan
  MRC TIDU Friday Morning Lab Meetings

Friday 13 May 2016

• 09:15 - Virus restriction and beyond: an update on SAMHD1
  Prof Jan Rehwinkel (WIMM HIU), Jonathan Maelfait, Tamara Davenne (WIMM, HIU)
  MRC TIDU Friday Morning Lab Meetings

Friday 20 May 2016

• 09:15 - Resolving TYK2 locus genotype-to-phenotype conflict reveals therapeutic optimum for autoimmunity
  Dr Calliope A Dendrou
  MRC TIDU Friday Morning Lab Meetings

Friday 27 May 2016

• 09:15 - To bnAb or not to bnAb- Are Tregs the answer?
  Dr Isabela Pedroza-Pacheco (Borrow Group, University of Oxford)
  MRC TIDU Friday Morning Lab Meetings

Monday 6 June 2016

• 13:00 - Regulation of lymphocyte development by RNA binding proteins
  Martin Turner (Babraham Institute, Cambridge)
  WIMM MONDAY SEMINARS

Wednesday 8 June 2016

• 13:30 - From Broadly Neutralising Antibodies to a New Mechanism of Diversification
  Professor Antonio Lanzavecchia (Director, Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland )
  MRC TIDU Wednesday Seminar Series

Friday 10 June 2016

• 09:15 - MAIT cell agonists: a novel class of adjuvants?
  Dr Mariolina Salio (MRC Human Immunology Unit, University of Oxford)
  MRC TIDU Friday Morning Lab Meetings

Thursday 16 June 2016

• 11:00 - Thymic development of Mucosal-Associated Invariant T (MAIT) cells
  Dr Daniel Pellicci (Research Fellow, University of Melbourne)

Friday 17 June 2016

• 09:15 - An update on investigation of IFITM3-rs12252C and its association with influenza virus infection
  Henry Laurenson-Schafer (University of Oxford)
  MRC TIDU Friday Morning Lab Meetings

Monday 20 June 2016

• 13:00 - Title TBC
  Martin Pule (Cancer Institute, UCL)
  WIMM MONDAY SEMINARS

Friday 24 June 2016

• 09:15 - Understanding the cellular response to atherogenic lipid
  Dr Anil Chalisey (University of Oxford)
  MRC TIDU Friday Morning Lab Meetings

Wednesday 13 July 2016

• 13:30 - Title TBC
  TBA

Tuesday 4 October 2016

• 13:00 - Introducing GSK Discovery Partnerships with Academia - Innovative Medicines from integrated industry-academia partnerships
  Dr Andrew Pearce (GSK Medicines Research Centre, Stevenage)
  Molecular Haematology Unit, WIMM

Wednesday 12 October 2016

• 13:30 - Improving the efficacy of cancer immunotherapy
  Prof Benoit Van den Eynde (Tumor Immunology Group, Ludwig Institute for Cancer Research)
  MRC TIDU Wednesday Seminar Series

Monday 31 October 2016

• 15:00 - Mucosal Associated Invariant T cells: Friend or Foe?
  PLEASE NOTE THE DATE (Monday 31st) and time (3pm) - not the usual slot
  Professor James McCluskey (University of Melbourne)
  MRC TIDU Wednesday Seminar Series

Wednesday 18 January 2017

• 13:30 - From happiness on twitter to the genome: Network based integrative approaches in epigenomics
  Dr Vera Pancaldi (Spanish National Cancer Research Centre, Madrid)
  MRC TIDU Wednesday Seminar Series

Thursday 26 January 2017

• 11:30 - The genetic and epigenetic principles of V(D)J recombination during B cell development
  Dr Hashem Koohy (Babraham Institute, Cambridge)
  MRC TIDU Wednesday Seminar Series

Wednesday 1 February 2017

• 13:30 - A DaNGeRous talk about dendritic cells
  Professor Caetano Reis e Sousa (Immunobiology Laboratory, The Francis Crick Institute, London)
  MRC TIDU Wednesday Seminar Series

Wednesday 19 April 2017

• 13:30 - New cancer immunotherapy strategies: the host is the target
  Dr Tobias Janowitz (University of Cambridge)
  MRC TIDU Wednesday Seminar Series

Wednesday 17 May 2017

• 13:30 - Exploiting neo-antigens for cancer immunotherapies
  Dr John Castle (Senior Director - Computational Biology & Genomics, AGENUS )
  MRC TIDU Wednesday Seminar Series

Monday 5 June 2017

• 13:00 - Evasion and chromatin-mediated silencing in HIV infection
  Paul Lehner (University of Cambridge School of Clinical Medicine)

Wednesday 14 June 2017

• 13:30 - Rare diseases as tools to understand autoimmunity
  Professor Olle Kämpe (Karolinska University Hospital)
  MRC TIDU Wednesday Seminar Series

Friday 7 July 2017

• 15:00 - Using NKT Cell Antigens as Vaccine Adjuvants
  Professor Ian Hermans (Malaghan Institute of Medical Research, New Zealand)
  MRC TIDU Wednesday Seminar Series

Wednesday 29 November 2017

• 13:30 - Catch me if you can – illuminating the onset of adaptive immunity
  Professor Robert Tampé (Goethe University Frankfurt)

Thursday 30 November 2017

• 14:30 - Discovery of Novel and Misfit Lipids that Control Human Macrophage Activation and T cell Response
  Professor Branch Moody (Division of Rheumatology, Immunology and Allergy Brigham and Women’s Hospital, Boston, USA)
  MRC TIDU Wednesday Seminar Series

Monday 15 January 2018

• 13:00 - PLEASE NOTE THIS SEMINAR AS BEEN CANCELLED
  Sebastian Amigorena (Institute Curie, Paris)
  WIMM MONDAY SEMINARS

Friday 25 May 2018

• 11:00 - CANCELLED: Translating Immunity: Literally
  Professor Jon Yewdell (Chief, Cellular Biology Section, Laboratory of Viral Diseases, NIAID, USA)
  MRC TIDU Wednesday Seminar Series

Friday 6 July 2018

• 13:00 - Immunotherapy of melanoma: where to next?
  Professor Rod Dunbar (The University of Auckland)

Tuesday 4 December 2018

• 11:00 - Salmonella species as initiators of gallbladder and colon carcinoma
  Professor Sjaak Neefjes (Leiden University)
  MRC TIDU Wednesday Seminar Series

Wednesday 13 March 2019

• 13:30 - Identification of relevant antigenic targets for successful liver cancer immunotherapy
  Professor Anna Pasetto (Karolinska Institutet)
  MRC TIDU Wednesday Seminar Series

Wednesday 27 March 2019

• 13:30 - Dissecting the role of programmed cell death-1 receptor (PD-1) in the immune system
  Dr Shoba Amarnath (Institute of Cellular Medicine, Newcastle University)
  MRC TIDU Wednesday Seminar Series

Wednesday 10 April 2019

• 11:30 - Democratising Live-Cell Compatible High-Speed Super-Resolution Microscopy
  Professor Ricardo Henriques (University College London)
  MRC TIDU Wednesday Seminar Series

Monday 24 February 2020

• 13:00 - Deciphering T cell evolution in lung cancer
  Status: This talk has been cancelled
  Dr Sergio Quezada (University College London)
  WIMM MONDAY SEMINARS